Last updated on September 2018

One-year Persistence to Treatment of Participants Receiving Flixabi: a French Cohort Study


Brief description of study

A study to describe the one-year persistence (participants still treated by Flixabi at 12 Months) in participants treated by Flixabi (infliximab) as prescribed by the physician for each of the 5 following indications: Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), Crohn's Disease (CD) [adults and children] and Ulcerative Colitis (UC) [adults and children].

Clinical Study Identifier: NCT03662919

Contact Investigators or Research Sites near you

Start Over

US Biogen Clinical Trial Center

Research Site
Bobigny, France
2.52miles
  Connect »

US Biogen Clinical Trial Center

Research Site
Clichy, France
7.68miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.